Form 4: Trulieve Director Foulston Receives Equity Grant

Trulieve Cannabis Corp. Director Matthew J. Foulston was granted 11,329 restricted stock units and 18,859 fully vested stock options on November 4, 2025.

Summary

• Matthew J. Foulston, a Director of Trulieve Cannabis Corp. (TRUL), acquired 11,329 subordinate voting shares through a grant of restricted stock units (RSUs) on November 4, 2025.
• Each RSU represents a contingent right to receive one Trulieve subordinate voting share, vesting on the earliest of the end of service on the board, a change of control of Trulieve, or December 1, 2031.
• Foulston also acquired 18,859 fully vested stock options with an exercise price of $6.62 per share on November 4, 2025.
• These stock options have an expiration date of December 1, 2032.

Sentiment

Score: 6

Explanation: This filing reports routine equity compensation for a director, which is generally viewed as a neutral to slightly positive event as it aligns director interests with shareholders. It does not contain information that would significantly alter the company's outlook.

Positives

• The grant of restricted stock units and fully vested stock options to a director aligns management's interests with those of shareholders, incentivizing long-term company performance.
• The options are fully vested immediately, providing immediate equity exposure and potential upside for the director.

Future Outlook

The Restricted Stock Units are designed to vest upon the earliest of the director's service termination, a change of control for Trulieve, or December 1, 2031, indicating a long-term incentive structure tied to the company's future events and the director's continued tenure.

Industry Context

This transaction is a standard form of executive and director compensation within publicly traded companies across various industries, including the cannabis sector. It reflects a common practice to incentivize leadership through equity ownership.

Comparison to Industry Standards

• Equity grants, including RSUs and stock options, are a common component of director compensation packages across publicly traded companies, aligning director interests with shareholder value.
• The vesting schedule for RSUs, tied to service, change of control, or a specific date, is typical for long-term incentive plans in many industries.
• The immediate vesting of stock options is less common than phased vesting but can be used to provide immediate equity exposure and reward for past or ongoing contributions.

Related Party Transactions

• The grant of restricted stock units and stock options to Matthew J. Foulston, a director of Trulieve Cannabis Corp., constitutes a related party transaction as it involves compensation from the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The equity grants align the director's financial interests with shareholder value, potentially leading to more shareholder-friendly decisions.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• The Restricted Stock Units will vest upon the earliest of the end of the reporting person's service on the board, a change of control of Trulieve, or December 1, 2031.
• The stock options, being fully vested, can be exercised by the director at any time before their expiration on December 1, 2032.

Key Dates

Recommendation

This Form 4 reports routine equity compensation for a director and does not provide sufficient new information to alter an investment thesis on Trulieve Cannabis Corp. It primarily serves to disclose insider holdings and compensation structure, which is a standard corporate governance practice. Investors should consider broader financial performance and market conditions for investment decisions.

Keywords

Trulieve Cannabis Corp., TRUL, Insider Transaction, Equity Grant, Restricted Stock Units, Stock Options, Director Compensation, Form 4, Cannabis Industry